August 21, 2023 11:24 AM EDT

FDA OKs Ingrezza for treating chorea associated with Huntington’s; Abivax inks agreement for up to $163M in debt financing

The FDA on Friday approved Neurocrine Biosciences’ Ingrezza to treat adults with chorea associated with Huntington’s disease.

Ingrezza, also known as …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA OKs In­grez­za for treat­ing chorea as­so­ci­at­ed with Hunt­ing­ton’s; Abi­vax inks agree­ment for up to $163M in debt fi­nanc­ing